Retinol-Binding Protein 4 Accelerates Metastatic Spread and Increases Impairment of Blood Flow in Mouse Mammary Gland Tumors

Cancers
Diana PapiernikJoanna Wietrzyk

Abstract

Retinol-binding protein 4 (RBP4) is proposed as an adipokine that links obesity and cancer. We analyzed the role of RBP4 in metastasis of breast cancer in patients and in mice bearing metastatic 4T1 and nonmetastatic 67NR mammary gland cancer. We compared the metastatic and angiogenic potential of these cells transduced with Rbp4 (4T1/RBP4 and 67NR/RBP4 cell lines). Higher plasma levels of RBP4 were observed in breast cancer patients with metastatic tumors than in healthy donors and patients with nonmetastatic cancer. Increased levels of RBP4 were observed in plasma, tumor tissue, liver, and abdominal fat. Moreover, the blood vessel network was highly impaired in mice bearing 4T1 as compared to 67NR tumors. RBP4 transductants showed further impairment of blood flow and increased metastatic potential. Exogenous RBP4 increased lung settlement by 67NR and 4T1 cells. In vitro studies showed increased invasive and clonogenic potential of cancer cells treated with or overexpressing RBP4. This effect is not dependent on STAT3 phosphorylation. RBP4 enhances the metastatic potential of breast cancer tumors through a direct effect on cancer cells and through increased endothelial dysfunction and impairment of blood vessels within the tumor.

References

May 1, 1997·Kidney International·P Pintavorn, B J Ballermann
Jan 28, 1998·Life Sciences·L MorbidelliM Ziche
Mar 16, 2001·Breast Cancer Research : BCR·G H HeppnerP M Shekhar
Jun 27, 2003·Transplantation Proceedings·B HosakaJ O Medina-Pestana
Jun 16, 2004·Vitamins and Hormones·Giuseppe Zanotti, Rodolfo Berni
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Dierk H Endemann, Ernesto L Schiffrin
Feb 17, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yao-Ching HungPei-San Se
Mar 14, 2007·Anti-cancer Drugs·Joanna WietrzykAdam Opolski
Sep 20, 2007·International Journal of Experimental Pathology·Sally A DuPréKenneth W Hunter
Dec 20, 2007·Journal of Cardiovascular Pharmacology·Marc Iglarz, Martine Clozel
Apr 25, 2008·Current Protocols in Immunology·B A Pulaski, S Ostrand-Rosenberg
Apr 5, 2011·Biochemical and Biophysical Research Communications·Kohzo TakebayashiToshihiko Inukai
Nov 2, 2011·Proteome Science·Pavel BouchalBorivoj Vojtesek
Oct 2, 2012·Scandinavian Journal of Clinical and Laboratory Investigation·Hala O El-MesallamyAlaliaa M Sallam
Feb 14, 2013·Mechanisms of Ageing and Development·Brian MeehanJanusz Rak
Jul 30, 2014·Mechanisms of Ageing and Development·Brian MeehanJanusz Rak
Sep 25, 2014·BioMed Research International·Yushan ChengZhenyu Zhang
Feb 7, 2015·Aging and Disease·Amanda Piano, Vladimir I Titorenko
Feb 26, 2015·Endocrine-related Cancer·Matthew V AbolaLi Li
Jul 3, 2015·Hormone Molecular Biology and Clinical Investigation·Noa NoyNathan A Berger
Sep 1, 2015·Pharmacological Reports : PR·Agnieszka BlazejczykJoanna Wietrzyk
Jul 15, 2016·Journal of Experimental & Clinical Cancer Research : CR·Agnieszka BlazejczykJoanna Wietrzyk
Nov 1, 2016·Diabetes·Spencer J ThompsonTimothy E Graham
Nov 9, 2016·International Journal of Oncology·Ewa MajJoanna Wietrzyk
Apr 8, 2017·Medical Science Monitor Basic Research·Daofang TangJingping Zhou
Dec 2, 2017·Oncotarget·Weiqiang FeiXiaotong Hu
Apr 13, 2018·Journal of Ovarian Research·Yanyan WangZhenyu Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
X-ray
Fluorescence
flow cytometry
Assay
ELISA
Protein Assay

Software Mentioned

Cheburator
VevoCQ
VevoLab
Carestream MI SE
Diva
Carestream MI
GraphPad Prism

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.